ChemBriefSenesTech Inc. Reports Form 4 Filing by Glenbrook Capital Management
Glenbrook Capital Management filed a Form 4 regarding transactions on October 28, coinciding with a 6.93% increase in SenesTech Inc. stock.
Investing.com Nigeria · 2026-10-31 06:21
← TagsCompany
SenesTech Inc
SenesTech, Inc. develops a technology for managing animal pest populations by controlling fertility. The company is headquartered in Phoenix, Arizona.
113 articles
Passive Investor Reports Over 5% Ownership in SenesTech (SNES)
Ranni Fakhoury disclosed a 5.02% beneficial ownership stake in SenesTech via Schedule 13G filing, holding 272,000 shares as of August 4, 2026.
Stock Titan · 2026-10-31 01:52
Glenbrook Capital Management Acquires 30,000 SenesTech (SNES) Shares
Glenbrook Capital Management purchased 30,000 common shares of SenesTech Inc., increasing its indirect holdings to over 2.1 million shares. The firm holds warrants for an additional 180,000 shares, cu
Stock Titan · 2026-10-31 00:52
SenesTech Hires Sandstrom Partners as Strategic Marketing Advisor
SenesTech has appointed Sandstrom Partners as a strategic advisor to enhance sales and branding for its Evolve and ContraPest rodent control products across e-commerce and B2B channels.
The Manila Times · 2026-10-28 19:40
SenesTech Rat Birth Control Program Deemed Successful in Chicago
SenesTech Inc.'s Evolve rodenticide achieved an 88% reduction in rat activity during a Chicago pilot. Additionally, rodent-related 911 calls decreased by 36% in the deployment area.
WLS 890 AM · 2026-10-28 14:13
Multiple Insiders Buy SenesTech Stock Signaling Confidence
SenesTech insiders purchased 300,770 shares worth $234k recently, signaling confidence despite losses. This net buying pattern suggests an optimistic outlook for the company.
Simply Wall Street · 2026-10-28 10:40
SenesTech, Inc. Estimates – NASDAQ:SNES
Overview of SenesTech Inc financials and analyst estimates on TradingView, covering reported financial data and trends with standard investment disclaimers.
TradingView · 2026-10-27 19:40
Glenbrook Capital Management Files Form 4 for SenesTech Inc
Glenbrook Capital Management filed a Form 4 report detailing insider transactions for SenesTech Inc on October 20, as the company's stock rose 5.77%.
Investing.com South Africa · 2026-10-23 10:12
SenesTech Receives Nasdaq Minimum Bid Price Notification and Highlights Record Third Quarter Revenue
SenesTech Inc reported record Q3 revenue of $1.1 million but faces Nasdaq delisting risks after trading below $1.00 for 30 days, aiming to regain compliance through financial management.
The Manila Times · 2026-10-23 02:41
SenesTech Receives Nasdaq Bid Price Non-Compliance Notice, Has Until April 19, 2027 to Regain Compliance
SenesTech Inc. received a Nasdaq notice for failing to maintain a minimum bid price, with until April 2027 to regain compliance, despite reporting record Q3 revenue growth.
Quiver Quantitative · 2026-10-22 16:40
SenesTech Inc Files Form 8K on October 22
SenesTech Inc filed a Form 8K on October 22, 2026, resulting in a 6.53% stock price increase. The filing is considered a significant corporate event for the biotechnology firm.
Investing.com Canada · 2026-10-22 12:42
Glenbrook Capital May Recommend Board Changes at SenesTech Following $4.33M Stake Acquisition
Glenbrook Capital Management acquired a 38.04% stake in SenesTech for $4.33 million and may recommend board changes following an amended Schedule 13D filing.
Stock Titan · 2026-10-19 21:11
Glenbrook Capital Management Discloses 30% Stake in SenesTech (SNES) Amid 40% Q3 Revenue Growth
Glenbrook Capital Management disclosed a stake exceeding 30% in SenesTech following 40% Q3 revenue growth. The firm cites undervaluation and insider optimism despite ongoing losses.
GuruFocus · 2026-10-19 20:11
Glenbrook Capital Acquires Over 30% Stake in SenesTech, Urges Strategy Shift
Glenbrook Capital Management acquired over a 30% stake in SenesTech, pushing for marketing and capital allocation changes, including equity-based compensation, despite the company's recent 40% top-lin
StreetInsider · 2026-10-19 19:11
Glenbrook Crosses 30% Ownership Stake in SenesTech
Glenbrook Capital Management has acquired over 30% of SenesTech, urging improved market strategy and capital discipline while engaging Sandstrom Partners for branding assistance.
TradingView · 2026-10-19 19:11
SenesTech Reports 36% Drop in Rat Calls After Chicago Evolve Pilot
SenesTech reported an 88% reduction in rat activity intensity during its Chicago Evolve pilot, correlating with a 36% drop in rodent-related 311 calls. Deployment expanded to six areas following preli
Stock Titan · 2026-10-19 11:41
SenesTech Inc (SNES) Stock Overview and Product Profile
SenesTech Inc (NASDAQ:SNES) specializes in rodent fertility control using its EPA-registered product ContraPest. The page displays stock market data and company mission information.
Proactive financial news · 2026-10-16 06:13
SenesTech Reports Preliminary Q3 Revenue of $1.1 Million
SenesTech Inc announced preliminary Q3 2026 revenue of $1.1 million, marking its first quarter exceeding the $1 million threshold. Growth was driven by e-commerce and business-to-business sales increa
Investing.com · 2026-10-15 13:13
SenesTech Q3FY26 Results: Preliminary revenue rises 55% YoY to $1.1M
SenesTech reported preliminary Q3 FY26 revenue of $1.1 million, up 55% YoY, driven by e-commerce subscriptions and B2B traction, marking its first quarter exceeding $1 million.
scanx.trade · 2026-10-15 12:40
SenesTech Preliminary Q3 Revenue Rises 55% Year-Over-Year to Quarterly High
SenesTech announced preliminary Q3 2026 revenue of approximately $1.1 million, marking its highest quarterly total. Growth was driven by e-commerce momentum and increasing B2B traction.
Stock Titan · 2026-10-15 12:40
SenesTech, Inc. (SNES) Posts Preliminary Q3 Revenue Of ~$1.1M, Up ~40% QoQ
SenesTech reported preliminary Q3 2026 revenue of approximately $1.1 million, marking its first quarter exceeding $1 million. This reflects a 40% quarter-over-quarter increase, with final financial de
TradingView · 2026-10-15 12:13
SenesTech Shifts to Rodent Birth Control: What It Means for SenesTech Stock
SenesTech Inc pivoted its strategy to focus on rodent birth control, achieving $770,000 Q2 2026 revenue with a 76.6% gross margin while targeting e-commerce growth to offset losses.
ad-hoc-news.de · 2026-10-14 05:11
SenesTech Stock Weighs Record Q2 Revenue Against a Tiny Base
SenesTech reported record Q2 revenue of $770,000 driven by Amazon sales of its rodent fertility control products, though negative cash flow highlights early-stage commercial challenges.
AD HOC NEWS · 2026-10-07 02:26
SenesTech Reports Record Q2 Revenue of $770,000
SenesTech Inc reported record Q2 2026 revenue of $770,000, a 56% increase driven by e-commerce and subscriptions. The company achieved a 76.60% gross margin despite a market capitalization of only $4.
AD HOC NEWS · 2026-10-06 15:26
SenesTech Inc. Files Form 4 for September 30
SenesTech Inc. submitted a Form 4 filing to the SEC on September 30, disclosing insider trading activity or changes in beneficial ownership of securities.
Investing.com India · 2026-09-30 06:25
SenesTech Adds Grove Channel as Q2 Revenue Hits USD 770,000
SenesTech secured a new sales channel with Grove Collaborative for its Evolve rodent birth control products, driving Q2 revenue up 56.19% to USD 770,000 despite a net loss.
AD HOC NEWS · 2026-09-29 18:28
SenesTech Partners with Grove Collaborative for Rodent Birth Control Distribution
SenesTech Inc partners with Grove Collaborative to distribute Evolve® rodent birth control products online. The EPA-compliant solution utilizes naturally derived ingredients for sustainable pest manag
Stock Titan · 2026-09-23 12:54
SenesTech, Inc. Adds Grove Collaborative as E-Commerce Channel
SenesTech announced its Evolve rodent birth control products will be available on Grove Collaborative's online marketplace, expanding distribution to sustainability-focused consumers. This strategic m
TradingView · 2026-09-23 12:54
SenesTech Expands Third-Party E-commerce Distribution With Grove Collaborative, Bringing Evolve Rodent Birth Control Products to Sustainability-Focused Consumers
SenesTech partners with Grove Collaborative to distribute Evolve rodent birth control products via e-commerce. This move targets sustainability-focused consumers and expands market reach for the envir
Moomoo · 2026-09-23 12:54
SenesTech stock lacks a verified market catalyst
SenesTech Inc. faces a lack of verified market catalysts for its stock, with analysts advising caution against confusing its ticker with Senseonics Holdings due to different market profiles.
AD HOC NEWS · 2026-09-22 14:15